Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys

[1]  S. Antimisiaris,et al.  Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[2]  W. Hsu,et al.  Mechanism of intranasal drug delivery directly to the brain , 2018, Life sciences.

[3]  Gilberto Alves,et al.  Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-O-Methyltransferase Inhibitors , 2017, Drug Metabolism and Disposition.

[4]  N. Nakamichi,et al.  Physiological Roles of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Neural Cells. , 2017, Biological & pharmaceutical bulletin.

[5]  Huidi Jiang,et al.  Multiple drug transporters mediate the placental transport of sulpiride , 2017, Archives of Toxicology.

[6]  R. Shamma,et al.  Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency , 2016, Drug delivery.

[7]  P. Pasinelli,et al.  Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders , 2015, Brain Research.

[8]  R. Thorne,et al.  Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  M. Ruigrok,et al.  Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans , 2015, The AAPS Journal.

[10]  Javed Ali,et al.  Insights into direct nose to brain delivery: current status and future perspective , 2014, Drug delivery.

[11]  H. Kusuhara,et al.  Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin. , 2013, Journal of pharmaceutical sciences.

[12]  T. Hummel,et al.  Olfactory bulb volume in smokers , 2013, Experimental Brain Research.

[13]  A. Misra,et al.  Drug delivery systems from nose to brain. , 2012, Current pharmaceutical biotechnology.

[14]  G. Sicard,et al.  Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium , 2012, PloS one.

[15]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[16]  F. Neiers,et al.  Expression and differential localization of xenobiotic transporters in the rat olfactory neuro-epithelium , 2011, Neuroscience Letters.

[17]  C. Surber,et al.  Nasal drug delivery in humans. , 2011, Current problems in dermatology.

[18]  Suzanne Skolnik,et al.  Attenuation of Intestinal Absorption by Major Efflux Transporters: Quantitative Tools and Strategies Using a Caco-2 Model , 2011, Drug Metabolism and Disposition.

[19]  N. Cherrington,et al.  Drug Transporter Expression and Localization in Rat Nasal Respiratory and Olfactory Mucosa and Olfactory Bulb , 2010, Drug Metabolism and Disposition.

[20]  Kenji Tabata,et al.  Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor , 2010, Drug Metabolism and Disposition.

[21]  G. Hankins,et al.  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. , 2010, American journal of obstetrics and gynecology.

[22]  W. Frey,et al.  Intranasal delivery to the central nervous system: mechanisms and experimental considerations. , 2010, Journal of pharmaceutical sciences.

[23]  L. Hanson,et al.  Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke , 2009, Journal of Pharmacology and Experimental Therapeutics.

[24]  K. Cosgrove,et al.  Evolving Knowledge of Sex Differences in Brain Structure, Function, and Chemistry , 2007, Biological Psychiatry.

[25]  S. Zeng,et al.  Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco‐2 , 2007, The Journal of pharmacy and pharmacology.

[26]  Kenji Yamada,et al.  Nose-to-brain delivery of TS-002, prostaglandin D2 analogue , 2007, Journal of drug targeting.

[27]  E. Björk,et al.  Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats , 2006, Pharmaceutical Research.

[28]  M. Donovan,et al.  Localization and Differential Activity of P-glycoprotein in the Bovine Olfactory and Nasal Respiratory Mucosae , 2005, Pharmaceutical Research.

[29]  L. Illum.  Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.

[30]  G. M. Pollack,et al.  P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation , 2003, Pharmaceutical Research.

[31]  K. Brouwer,et al.  Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers , 2002, Journal of Pharmacology and Experimental Therapeutics.

[32]  S. Yamashita,et al.  Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs , 1995, The Journal of pharmacy and pharmacology.

[33]  S. Yamashita,et al.  Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug , 1994, The Journal of pharmacy and pharmacology.

[34]  S. Gizurarson.  The relevance of nasal physiology to the design of drug absorption studies , 1993 .

[35]  M. Hashida,et al.  The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. , 1991, Chemical & pharmaceutical bulletin.

[36]  M. Hashida,et al.  Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity , 1991, The Journal of pharmacy and pharmacology.

[37]  J. Unadkat,et al.  Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update , 2014, The AAPS Journal.

[38]  S. Oswald,et al.  In vivo probes of drug transport: commonly used probe drugs to assess function of intestinal P-glycoprotein (ABCB1) in humans. , 2011, Handbook of experimental pharmacology.

[39]  I. Hidalgo,et al.  Nasal delivery of P-gp substrates to the brain through the nose-brain pathway. , 2011, Drug metabolism and pharmacokinetics.

[40]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[41]  F. Merkus,et al.  Can Nasal Drug Delivery Bypass the Blood-Brain Barrier? , 2007, Drugs in R&D.